Video 1
Video 2
Video 3
Acne often appears to worsen before it improves because many effective treatments act at the level of microcomedones, the earliest invisible stage of clogged pore formation. Acne begins when excess sebum production combines with abnormal follicular keratinization, leading to the buildup of dead skin cells inside the pore. These microscopic blockages can exist beneath the surface for weeks before becoming visible as blackheads, whiteheads, or inflamed lesions. When treatments such as topical retinoids accelerate cell turnover and normalize shedding within the follicle, they may bring these pre-existing microcomedones to the surface more rapidly. This process can temporarily increase visible breakouts, even though it reflects underlying therapeutic activity.
Topical retinoids are particularly associated with this phenomenon. By binding to retinoic acid receptors in skin cells, they help regulate desquamation and reduce the formation of new clogged pores. However, during the early weeks of use, the increased cellular turnover can make existing lesions emerge in a more condensed timeframe. This is sometimes referred to as a “purge,” although the term can be misused. True treatment-related flares typically occur in areas where acne already forms and gradually stabilize as the follicular cycle normalizes. In contrast, widespread irritation or new breakouts in previously unaffected areas may indicate product intolerance rather than expected adjustment.
Other active ingredients can also contribute to temporary changes in the skin. Salicylic acid exfoliates within oily pores, loosening debris and potentially revealing underlying comedones. Benzoyl peroxide reduces bacterial load and inflammation but may initially dry the skin, leading to barrier disruption if introduced too aggressively. When the skin barrier becomes compromised, increased transepidermal water loss can trigger compensatory oil production and heightened sensitivity, which may amplify the appearance of acne lesions.
Hormonal fluctuations can overlap with early treatment phases and complicate interpretation. Androgens stimulate sebaceous gland activity, and shifts related to menstrual cycles, stress hormones, or life stages may temporarily increase sebum output. Because acne is multifactorial, improvements in follicular keratinization may not immediately offset hormonally driven oil production. Genetics and individual immune reactivity also influence how quickly inflammation subsides once treatment begins.
Modern acne management emphasizes gradual introduction of active ingredients to reduce unnecessary irritation. Using retinoids every other night initially, applying a non-comedogenic moisturizer to support barrier function, and avoiding excessive layering of exfoliating products may help minimize early flares. Niacinamide can be incorporated to calm inflammation and regulate sebum, while ceramide-containing moisturizers reinforce barrier integrity. Consistency is critical, as many acne treatments require eight to twelve weeks to demonstrate visible improvement due to the natural lifecycle of the follicle.
It is important to set realistic expectations. Acne treatments are designed to reduce the formation of new clogged pores and control inflammation over time, not to eliminate lesions overnight. Temporary worsening does not necessarily indicate treatment failure. However, severe irritation, cystic flares, or worsening scarring should prompt evaluation by a qualified dermatologist. In some cases, prescription-strength therapies or systemic medications may be required to achieve control.
Understanding why acne can flare before improvement helps frame early changes as part of a biological adjustment process rather than a setback. With careful product selection, barrier-conscious skincare, and patience, many individuals experience gradual stabilization as the skin adapts and the rate of new lesion formation declines.
